Purdue University researchers in the College of Agriculture, College of Pharmacy and College of Science have received $175,000 from the Trask Innovation Fund to develop Purdue-owned intellectual property for commercial use. The innovations are in the areas of cancer therapeutics, cellular targeting and manipulation, and superabsorbent materials.
The fund is managed by the Purdue Innovates Incubator, which provides programming for the Purdue University community to ideate, refine and support their solutions. Funding recipients can receive up to $50,000 for their initial project; they may reapply a maximum of three times to receive up to an aggregate cap of $100,000 to support the same technology.
Between the 2013 and 2023 fiscal years, around $3 million in Trask funding has been awarded to 81 projects. Forty percent of the technologies that have received Trask funding have been licensed or optioned to industry.
The application deadline for the next round of funding is Sept. 27. The Trask Proposal Template can be downloaded and edited. Questions about applications can be submitted to trask@prf.org.
The spring 2024 Trask Innovation Fund recipients, their projects and award amounts can be found here: Purdue researchers receive $175K from Purdue Innovates to strengthen market readiness of their work – News
